Hauser, Blake M. https://orcid.org/0000-0002-0100-1684
Luo, Yuyang
Nathan, Anusha
Al-Moujahed, Ahmad
Vavvas, Demetrios G. https://orcid.org/0000-0002-8622-6478
Comander, Jason
Pierce, Eric A.
Place, Emily M.
Bujakowska, Kinga M. https://orcid.org/0000-0001-6809-9818
Gaiha, Gaurav D. https://orcid.org/0000-0001-6875-4472
Rossin, Elizabeth J. https://orcid.org/0000-0002-0052-9575
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Eye Institute (K12EY016335)
Massachusetts Lions Eye Research Fund
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (T32GM144273)
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (F30AI160908, DP2AI154421, R01AI176533, DP1DA058476)
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases
Bill and Melinda Gates Foundation
Burroughs Wellcome Fund
Article History
Received: 15 November 2023
Accepted: 2 May 2024
First Online: 27 May 2024
Competing interests
: G.D.G. discloses research funding from Merck. E.J.R. and G.D.G. have filed two patent applications related to the use of SBNA in HIV and SARS-CoV-2.